Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Hetacillin potassium [USAN:USP:JAN]
RN: 5321-32-4
UNII: 95PFX5932Y
InChIKey: QRSPJBLLJXVPDD-XFAPPKAWSA-M

Classification Codes

  • Antibacterial
  • Drug / Therapeutic Agent

Molecular Formula

  • C19-H23-N3-O4-S.K

Molecular Weight

  • 427.5638
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Hetacillin potassium
  • Hetacillin potassium [USAN:USP:JAN]

Synonyms

  • 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, monopotassium salt, (2S-(2alpha,5alpha,6beta(S*)))-
  • EINECS 226-182-3
  • H-K Mastitis (Veterinary)
  • Hetacillin potassium
  • Hetacin-K (Veterinary)
  • Natacillin
  • Potassium 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
  • Potassium hetacillin
  • UNII-95PFX5932Y
  • Versapen-K

Systematic Names

  • 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, monopotassium salt, (2S-(2alpha,5alpha,6beta(S*)))-
  • 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-imidazolinyl)-3,3-dimethyl-7-oxo-, monopotassium salt
  • Potassium (2S-(2alpha,5alpha,6beta(S*)))-6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate

Registry Numbers

CAS Registry Number

  • 5321-32-4

FDA UNII

  • 95PFX5932Y

Other Registry Numbers

  • 26939-80-0
  • 4052-56-6

System Generated Number

  • 0005321324

Molecular Formulas

Molecular Formula

  • C19-H23-N3-O4-S.K

Molecular Formula Fragments

  • C19-H23-N3-O4-S
  • COMPONENT
  • K

Structure Descriptors

InChI

1S/C19H23N3O4S.K/c1-18(2)13(17(25)26)21-15(24)12(16(21)27-18)22-14(23)11(20-19(22,3)4)10-8-6-5-7-9-10;/h5-9,11-13,16,20H,1-4H3,(H,25,26);/q;+1/p-1/t11-,12-,13+,16-;/m1./s1

InChIKey

QRSPJBLLJXVPDD-XFAPPKAWSA-M

Smiles

[K+].CC1(C)S[C@@H]2[C@H](N3C(=O)[C@H](NC3(C)C)c4ccccc4)C(=O)N2[C@H]1C(=O)[O-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 2200mg/kg (2200mg/kg)   Drugs in Japan Vol. -, Pg. 1066, 1990.
dog LD50 oral > 4gm/kg (4000mg/kg)   Drugs in Japan Vol. 6, Pg. 748, 1982.
dog LD50 subcutaneous > 4gm/kg (4000mg/kg)   Drugs in Japan Vol. -, Pg. 1066, 1990.
mouse LD50 intravenous 650mg/kg (650mg/kg)   Drugs in Japan Vol. -, Pg. 1066, 1990.
mouse LD50 oral > 15gm/kg (15000mg/kg)   Drugs in Japan Vol. 6, Pg. 748, 1982.
mouse LD50 subcutaneous > 12gm/kg (12000mg/kg)   Drugs in Japan Vol. -, Pg. 1066, 1990.
rat LD50 intravenous > 1400mg/kg (1400mg/kg)   Drugs in Japan Vol. -, Pg. 1066, 1990.
rat LD50 oral > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. 6, Pg. 748, 1982.
rat LD50 subcutaneous > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. -, Pg. 1066, 1990.